Development of a novel class of interleukin-2 immunotherapies for metastatic cancer. Swiss Med Wkly [Internet]. 2019 Jan. 23 [cited 2025 Oct. 13];149(0304):w14697. Available from: https://www.smw.ch/index.php/smw/article/view/2564